Contraceptive Agents, Female
Research News and Information

Monday, November 23, 2009

Short communication: Effect of estrogen supplemented at dry-off on temporal changes in concentrations of lactose in blood plasma of Holstein cows.

30 Jul 2009 The objective was to determine the effect of supplemental estrogen (estradiol cypionate, ECP) at dry-off on temporal changes in concentrations of lactose in blood plasma of Holstein cows as an indicator of rate of mammary involution. Thirty-two ... Read more...

Early weight gain predicting later weight gain among depot medroxyprogesterone acetate users.

30 Jul 2009 OBJECTIVE: To examine if early weight gain in depot medroxyprogesterone acetate (DMPA) users predicts continued excessive weight gain and to identify risk factors of early weight gain in DMPA users. METHODS: Depot medroxyprogesterone acetate users ... Read more...

Choosing the best contraceptive method for the adult with congenital heart disease.

29 Jun 2009 As women with congenital heart disease (CHD) approach childbearing age, issues such as pregnancy and contraception need to be addressed. Women with CHD represent a heterogeneous population. While some have simple cardiac lesions and thus have ... Read more...

Latest indexed articles for 'Contraceptive Agents, Female'

These are the very latest articles for this heading:

• Localised lipoatrophy at the site of Implanon insertion. 29 Sep 2009
• Implant location technique. 29 Sep 2009
• Pregnancy at time of change of Implanon implant. 29 Sep 2009
• Same-day initiation of hormonal contraceptives. 29 Sep 2009
• Short communication: Effect of estrogen supplemented at dry-off on temporal changes in concentrations of lactose in blood plasma of Holstein cows. 30 Jul 2009
• Early weight gain predicting later weight gain among depot medroxyprogesterone acetate users. 30 Jul 2009
• Contraceptive patch and vaginal ring vs. combined oral contraceptives. 30 Jul 2009
• A third of women in UK who have an unintended pregnancy blame contraceptive failure. 20 Jul 2009
• Choosing the best contraceptive method for the adult with congenital heart disease. 29 Jun 2009
• Autoimmune progesterone dermatitis. 29 Jun 2009
• Reversible contraception update: the importance of long-acting reversible contraception. 29 Jun 2009
• Eligibility criteria in venous thromboembolism, myocardial infarction, and stroke among transdermal contraceptive system users. 29 Jun 2009
• The role of toll-like receptors (TLR-2 and -4) and triggering receptor expressed on myeloid cells 1 (TREM-1) in human term and preterm labor. 27 Jun 2009
• WHO provider brief on hormonal contraception and liver disease. 11 Jun 2009
• Use of contraceptive methods by women with current venous thrombosis on anticoagulant therapy: a systematic review. 8 Jun 2009
• Menstrual suppression for adolescents with developmental disabilities. 30 May 2009
• Comparison of the effects of the levonorgestrel-releasing intrauterine system (Mirena) and depot-medroxyprogesterone acetate (Depo-Provera) on subendometrial microvascularisation and uterine artery blood flow. 30 May 2009
• Profile of long-acting reversible contraception users in Europe. 30 May 2009
• The effect of the levonorgestrel releasing intrauterine system on endometrial hyperplasia: an Australian study and systematic review. 30 May 2009
• Internal or infernal devices: experiences of contraception among Australian women living with hepatitis C. 30 May 2009

See a longer list of these articles.

Technical information about 'Contraceptive Agents, Female'

Definition: Chemical substances or agents with contraceptive activity in females. Use for female contraceptive agents in general or for which there is no specific heading.

Registry Number: 0

Descriptor UI: D003271

Alternative terms: Contraceptive Agents, Female; Agents, Female Contraceptive; Female Contraceptive Agents; Contraceptives, Female; Female Contraceptives;

Related Mesh Headings: Vaginal Creams, Foams, and Jellies;

Allowable Qualifiers: administration & dosage; adverse effects; analysis; antagonists & inhibitors; blood; cerebrospinal fluid; chemical synthesis; classification; diagnostic use; economics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; poisoning; radiation effects; standards; supply & distribution; therapeutic use; toxicity; urine; chemistry; contraindications; agonists;

Tree Number: D27.505.696.875.360.276; D27.505.954.705.360.276;

History Note: 75

Technical Notes: pregn despite use: see note on CONTRACEPTIVE AGENTS